WHO ICTRP trial
Comparison Of Hypofractionated And Conventional Radiotherapy In Advanced Breast…
IRCT20250728066668N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20250728066668N1 |
|---|---|
| Public title | Comparison Of Hypofractionated And Conventional Radiotherapy In Advanced Breast Cancer |
| Scientific title | Comparison Of Local Control And Complications Of Hypofractionated Radiotherapy With Conventional In Patients With Advanced Breast Cancer |
| Primary sponsor | Babol University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Breast Cancer. Malignant neoplasm of breast |
| Interventions | Intervention 1: Intervention Group:Patients with advanced breast cancer undergo hypofractionated radiotherapy treatment for three weeks. During treatment, they are monitored weekly for complications based on the aforementioned criteria, and… |
| Registration date | Aug 1, 2025 |
| Target size | 200 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: